APO Research
Talk to an analyst

APO RESEARCH · REPORT

Omadacycline API

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Omadacycline API Industry Growth and Trends Forecast to 2032

19 December 202594 pages

Choose your research edition.

Industry ResearchOmadacycline API Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Omadacycline API Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Omadacycline API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Omadacycline API Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Omadacycline API Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Omadacycline API market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Omadacycline API is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Omadacycline API is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Omadacycline API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Omadacycline API include Sichuan Qingmu Pharmaceutical, Sichuan Kelun Pharmaceutical, Sichuan Aobang Gude Pharmaceutical, Shanghai Desano Chemical Pharmaceutical, Asymchem Laboratories, Hubei Tianshu Pharmaceutical and Paratek Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Omadacycline API market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Omadacycline API market size, estimates, and forecasts are presented in terms of sales volume (kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Omadacycline API market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Omadacycline API.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Omadacycline API market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Omadacycline API Market by Company

Sichuan Qingmu Pharmaceutical

Sichuan Kelun Pharmaceutical

Sichuan Aobang Gude Pharmaceutical

Shanghai Desano Chemical Pharmaceutical

Asymchem Laboratories

Hubei Tianshu Pharmaceutical

Paratek Pharmaceuticals

Omadacycline API Segment by Type

Purity 97%-99%

Purity Above 99%

Omadacycline API Segment by Application

Injection

Tablets

Omadacycline API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Omadacycline API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Omadacycline API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Omadacycline API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Omadacycline API manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Omadacycline API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Purity 97%-99% Table 2. Major Company of Purity Above 99% Table 3. Global Omadacycline API Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Omadacycline API Sales by Type (2021-2026) & (kg) Table 5. Global Omadacycline API Sales Market Share in Volume by Type (2021-2026) Table 6. Global Omadacycline API Sales by Type (2021-2026) & (US$ Million) Table 7. Global Omadacycline API Sales Market Share in Value by Type (2021-2026) Table 8. Global Omadacycline API Price by Type (2021-2026) & (USD/kg) Table 9. Global Omadacycline API Sales by Type (2027-2032) & (kg) Table 10. Global Omadacycline API Sales Market Share in Volume by Type (2027-2032) Table 11. Global Omadacycline API Sales by Type (2027-2032) & (US$ Million) Table 12. Global Omadacycline API Sales Market Share in Value by Type (2027-2032) Table 13. Global Omadacycline API Price by Type (2027-2032) & (USD/kg) Table 14. North America Omadacycline API Sales by Type (2021-2026) & (kg) Table 15. North America Omadacycline API Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Omadacycline API Sales by Type (2021-2026) & (kg) Table 17. Europe Omadacycline API Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Omadacycline API Sales by Type (2021-2026) & (kg) Table 19. Asia-Pacific Omadacycline API Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Omadacycline API Sales by Type (2021-2026) & (kg) Table 21. Latin America Omadacycline API Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Omadacycline API Sales by Type (2021-2026) & (kg) Table 23. Middle East and Africa Omadacycline API Sales by Type (2021-2026) & (US$ Million) Table 24. Omadacycline API Industry Trends Table 25. Omadacycline API Industry Drivers Table 26. Omadacycline API Industry Opportunities and Challenges Table 27. Omadacycline API Industry Restraints Table 28. Global Omadacycline API Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Omadacycline API Revenue Market Share by Company (2021-2026) Table 30. Global Omadacycline API Sales by Company (2021-2026) & (kg) Table 31. Global Omadacycline API Sales Share by Company (2021-2026) Table 32. Global Omadacycline API Market Price by Company (2021-2026) & (USD/kg) Table 33. Global Omadacycline API Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Omadacycline API Major Company Production Sites and Headquarters Table 35. Global Omadacycline API Company, Product Type & Application Table 36. Global Omadacycline API Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Omadacycline API by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Omadacycline API Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Omadacycline API Sales by Region (2021-2026) & (kg) Table 41. Global Omadacycline API Sales Market Share in Volume by Region (2021-2026) Table 42. Global Omadacycline API Sales by Region (2021-2026) & (US$ Million) Table 43. Global Omadacycline API Sales Market Share in Value by Region (2021-2026) Table 44. Global Omadacycline API Sales (kg), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 45. Global Omadacycline API Sales by Region (2027-2032) & (kg) Table 46. Global Omadacycline API Sales Market Share in Volume by Region (2027-2032) Table 47. Global Omadacycline API Sales by Region (2027-2032) & (US$ Million) Table 48. Global Omadacycline API Sales Market Share in Value by Region (2027-2032) Table 49. Global Omadacycline API Sales (kg), Value (US$ Million), Price (USD/kg) and Gross Margin (2027-2032) Table 50. Global Omadacycline API Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Omadacycline API Sales by Application (2021-2026) & (kg) Table 52. Global Omadacycline API Sales Market Share in Volume by Application (2021-2026) Table 53. Global Omadacycline API Sales by Application (2021-2026) & (US$ Million) Table 54. Global Omadacycline API Sales Market Share in Value by Application (2021-2026) Table 55. Global Omadacycline API Price by Application (2021-2026) & (USD/kg) Table 56. Global Omadacycline API Sales by Application (2027-2032) & (kg) Table 57. Global Omadacycline API Sales Market Share in Volume by Application (2027-2032) Table 58. Global Omadacycline API Sales by Application (2027-2032) & (US$ Million) Table 59. Global Omadacycline API Sales Market Share in Value by Application (2027-2032) Table 60. Global Omadacycline API Price by Application (2027-2032) & (USD/kg) Table 61. North America Omadacycline API Sales by Application (2021-2026) & (kg) Table 62. North America Omadacycline API Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Omadacycline API Sales by Application (2021-2026) & (kg) Table 64. Europe Omadacycline API Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Omadacycline API Sales by Application (2021-2026) & (kg) Table 66. Asia-Pacific Omadacycline API Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Omadacycline API Sales by Application (2021-2026) & (kg) Table 68. Latin America Omadacycline API Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Omadacycline API Sales by Application (2021-2026) & (kg) Table 70. Middle East and Africa Omadacycline API Sales by Application (2021-2026) & (US$ Million) Table 71. Sichuan Qingmu Pharmaceutical Company Information Table 72. Sichuan Qingmu Pharmaceutical Business Overview Table 73. Sichuan Qingmu Pharmaceutical Omadacycline API Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 74. Sichuan Qingmu Pharmaceutical Omadacycline API Product Portfolio Table 75. Sichuan Qingmu Pharmaceutical Recent Development Table 76. Sichuan Kelun Pharmaceutical Company Information Table 77. Sichuan Kelun Pharmaceutical Business Overview Table 78. Sichuan Kelun Pharmaceutical Omadacycline API Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 79. Sichuan Kelun Pharmaceutical Omadacycline API Product Portfolio Table 80. Sichuan Kelun Pharmaceutical Recent Development Table 81. Sichuan Aobang Gude Pharmaceutical Company Information Table 82. Sichuan Aobang Gude Pharmaceutical Business Overview Table 83. Sichuan Aobang Gude Pharmaceutical Omadacycline API Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 84. Sichuan Aobang Gude Pharmaceutical Omadacycline API Product Portfolio Table 85. Sichuan Aobang Gude Pharmaceutical Recent Development Table 86. Shanghai Desano Chemical Pharmaceutical Company Information Table 87. Shanghai Desano Chemical Pharmaceutical Business Overview Table 88. Shanghai Desano Chemical Pharmaceutical Omadacycline API Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 89. Shanghai Desano Chemical Pharmaceutical Omadacycline API Product Portfolio Table 90. Shanghai Desano Chemical Pharmaceutical Recent Development Table 91. Asymchem Laboratories Company Information Table 92. Asymchem Laboratories Business Overview Table 93. Asymchem Laboratories Omadacycline API Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 94. Asymchem Laboratories Omadacycline API Product Portfolio Table 95. Asymchem Laboratories Recent Development Table 96. Hubei Tianshu Pharmaceutical Company Information Table 97. Hubei Tianshu Pharmaceutical Business Overview Table 98. Hubei Tianshu Pharmaceutical Omadacycline API Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 99. Hubei Tianshu Pharmaceutical Omadacycline API Product Portfolio Table 100. Hubei Tianshu Pharmaceutical Recent Development Table 101. Paratek Pharmaceuticals Company Information Table 102. Paratek Pharmaceuticals Business Overview Table 103. Paratek Pharmaceuticals Omadacycline API Sales (kg), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 104. Paratek Pharmaceuticals Omadacycline API Product Portfolio Table 105. Paratek Pharmaceuticals Recent Development Table 106. North America Omadacycline API Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 107. North America Omadacycline API Sales by Country (2021-2026) & (kg) Table 108. North America Omadacycline API Sales Market Share by Country (2021-2026) Table 109. North America Omadacycline API Sales Forecast by Country (2027-2032) & (kg) Table 110. North America Omadacycline API Sales Market Share Forecast by Country (2027-2032) Table 111. North America Omadacycline API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. North America Omadacycline API Market Size by Country (2021-2026) & (US$ Million) Table 113. North America Omadacycline API Market Share by Country (2021-2026) Table 114. North America Omadacycline API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. North America Omadacycline API Market Share Forecast by Country (2027-2032) Table 116. Europe Omadacycline API Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 117. Europe Omadacycline API Sales by Country (2021-2026) & (kg) Table 118. Europe Omadacycline API Sales Market Share by Country (2021-2026) Table 119. Europe Omadacycline API Sales Forecast by Country (2027-2032) & (kg) Table 120. Europe Omadacycline API Sales Market Share Forecast by Country (2027-2032) Table 121. Europe Omadacycline API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Europe Omadacycline API Market Size by Country (2021-2026) & (US$ Million) Table 123. Europe Omadacycline API Market Share by Country (2021-2026) Table 124. Europe Omadacycline API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Europe Omadacycline API Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Omadacycline API Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Omadacycline API Sales by Country (2021-2026) & (kg) Table 128. Asia-Pacific Omadacycline API Sales Market Share by Country (2021-2026) Table 129. Asia-Pacific Omadacycline API Sales Forecast by Country (2027-2032) & (kg) Table 130. Asia-Pacific Omadacycline API Sales Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Omadacycline API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Omadacycline API Market Size by Country (2021-2026) & (US$ Million) Table 133. Asia-Pacific Omadacycline API Market Share by Country (2021-2026) Table 134. Asia-Pacific Omadacycline API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Asia-Pacific Omadacycline API Market Share Forecast by Country (2027-2032) Table 136. Latin America Omadacycline API Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 137. Latin America Omadacycline API Sales by Country (2021-2026) & (kg) Table 138. Latin America Omadacycline API Sales Market Share by Country (2021-2026) Table 139. Latin America Omadacycline API Sales Forecast by Country (2027-2032) & (kg) Table 140. Latin America Omadacycline API Sales Market Share Forecast by Country (2027-2032) Table 141. Latin America Omadacycline API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Latin America Omadacycline API Market Size by Country (2021-2026) & (US$ Million) Table 143. Latin America Omadacycline API Market Share by Country (2021-2026) Table 144. Latin America Omadacycline API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Latin America Omadacycline API Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Omadacycline API Market Size Growth Rate (CAGR) by Country (kg): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Omadacycline API Sales by Country (2021-2026) & (kg) Table 148. Middle East and Africa Omadacycline API Sales Market Share by Country (2021-2026) Table 149. Middle East and Africa Omadacycline API Sales Forecast by Country (2027-2032) & (kg) Table 150. Middle East and Africa Omadacycline API Sales Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Omadacycline API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Omadacycline API Market Size by Country (2021-2026) & (US$ Million) Table 153. Middle East and Africa Omadacycline API Market Share by Country (2021-2026) Table 154. Middle East and Africa Omadacycline API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Middle East and Africa Omadacycline API Market Share Forecast by Country (2027-2032) Table 156. Key Raw Materials Table 157. Raw Materials Key Suppliers Table 158. Omadacycline API Distributors List Table 159. Omadacycline API Customers List Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. Omadacycline API Image Figure 2. Global Omadacycline API Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Omadacycline API Market Size (2021-2032) & (US$ Million) Figure 4. Global Omadacycline API Sales (2021-2032) & (kg) Figure 5. Purity 97%-99% Image Figure 6. Global Purity 97%-99% Sales YoY Growth (2021-2032) & (kg) Figure 7. Purity Above 99% Image Figure 8. Global Purity Above 99% Sales YoY Growth (2021-2032) & (kg) Figure 9. Global Omadacycline API Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Omadacycline API Market Share by Type 2025 VS 2032 Figure 11. North America Omadacycline API Sales Market Share in Volume by Type in 2025 Figure 12. North America Omadacycline API Sales Market Share in Value by Type in 2025 Figure 13. Europe Omadacycline API Sales Market Share in Volume by Type in 2025 Figure 14. Europe Omadacycline API Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Omadacycline API Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Omadacycline API Sales Market Share in Value by Type in 2025 Figure 17. Latin America Omadacycline API Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Omadacycline API Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Omadacycline API Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Omadacycline API Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Omadacycline API Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Injection Image Figure 24. Global Injection Sales YoY Growth (2021-2032) & (kg) Figure 25. Tablets Image Figure 26. Global Tablets Sales YoY Growth (2021-2032) & (kg) Figure 27. Global Omadacycline API Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Omadacycline API Market Share by Application 2025 VS 2032 Figure 29. North America Omadacycline API Sales Market Share in Volume by Application in 2025 Figure 30. North America Omadacycline API Sales Market Share in Value by Application in 2025 Figure 31. Europe Omadacycline API Sales Market Share in Volume by Application in 2025 Figure 32. Europe Omadacycline API Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Omadacycline API Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Omadacycline API Sales Market Share in Value by Application in 2025 Figure 35. Latin America Omadacycline API Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Omadacycline API Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Omadacycline API Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Omadacycline API Sales Market Share in Value by Application in 2025 Figure 39. North America Omadacycline API Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 40. North America Omadacycline API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Omadacycline API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Omadacycline API Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Omadacycline API Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 44. Europe Omadacycline API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Omadacycline API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Omadacycline API Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Omadacycline API Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 48. Asia-Pacific Omadacycline API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Omadacycline API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Omadacycline API Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Omadacycline API Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 52. Latin America Omadacycline API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Omadacycline API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Omadacycline API Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Omadacycline API Sales by Country: 2021 VS 2025 VS 2032 (kg) Figure 56. Middle East and Africa Omadacycline API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Omadacycline API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Omadacycline API Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Omadacycline API Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Omadacycline API Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Purity 97%-99%
  • Purity Above 99%
Applications
  • Injection
  • Tablets
Companies covered
  • Sichuan Qingmu Pharmaceutical
  • Sichuan Kelun Pharmaceutical
  • Sichuan Aobang Gude Pharmaceutical
  • Shanghai Desano Chemical Pharmaceutical
  • Asymchem Laboratories
  • Hubei Tianshu Pharmaceutical
  • Paratek Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Omadacycline API Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Omadacycline API Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Omadacycline API Market by Type
  6. 1.3.1 Purity 97%-99%
  7. 1.3.2 Purity Above 99%
  8. 1.4 Global Omadacycline API Market Size by Type
  9. 1.4.1 Global Omadacycline API Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Omadacycline API Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Omadacycline API Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Omadacycline API Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Omadacycline API Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Omadacycline API Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Omadacycline API Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Omadacycline API Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Omadacycline API Industry Trends
  2. 2.2 Omadacycline API Industry Drivers
  3. 2.3 Omadacycline API Industry Opportunities and Challenges
  4. 2.4 Omadacycline API Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Omadacycline API Revenue (2021-2026)
  2. 3.2 Global Top Players by Omadacycline API Sales (2021-2026)
  3. 3.3 Global Top Players by Omadacycline API Price (2021-2026)
  4. 3.4 Global Omadacycline API Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Omadacycline API Major Company Production Sites & Headquarters
  6. 3.6 Global Omadacycline API Company, Product Type & Application
  7. 3.7 Global Omadacycline API Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Omadacycline API Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Omadacycline API Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Omadacycline API Tier 1, Tier 2, and Tier 3
4 Omadacycline API Regional Status and Outlook
  1. 4.1 Global Omadacycline API Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Omadacycline API Historic Market Size by Region
  3. 4.2.1 Global Omadacycline API Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Omadacycline API Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Omadacycline API Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Omadacycline API Forecasted Market Size by Region
  7. 4.3.1 Global Omadacycline API Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Omadacycline API Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Omadacycline API Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Omadacycline API by Application
  1. 5.1 Omadacycline API Market by Application
  2. 5.1.1 Injection
  3. 5.1.2 Tablets
  4. 5.2 Global Omadacycline API Market Size by Application
  5. 5.2.1 Global Omadacycline API Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Omadacycline API Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Omadacycline API Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Omadacycline API Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Omadacycline API Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Omadacycline API Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Omadacycline API Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Omadacycline API Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sichuan Qingmu Pharmaceutical
  2. 6.1.1 Sichuan Qingmu Pharmaceutical Company Information
  3. 6.1.2 Sichuan Qingmu Pharmaceutical Business Overview
  4. 6.1.3 Sichuan Qingmu Pharmaceutical Omadacycline API Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sichuan Qingmu Pharmaceutical Omadacycline API Product Portfolio
  6. 6.1.5 Sichuan Qingmu Pharmaceutical Recent Developments
  7. 6.2 Sichuan Kelun Pharmaceutical
  8. 6.2.1 Sichuan Kelun Pharmaceutical Company Information
  9. 6.2.2 Sichuan Kelun Pharmaceutical Business Overview
  10. 6.2.3 Sichuan Kelun Pharmaceutical Omadacycline API Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sichuan Kelun Pharmaceutical Omadacycline API Product Portfolio
  12. 6.2.5 Sichuan Kelun Pharmaceutical Recent Developments
  13. 6.3 Sichuan Aobang Gude Pharmaceutical
  14. 6.3.1 Sichuan Aobang Gude Pharmaceutical Company Information
  15. 6.3.2 Sichuan Aobang Gude Pharmaceutical Business Overview
  16. 6.3.3 Sichuan Aobang Gude Pharmaceutical Omadacycline API Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sichuan Aobang Gude Pharmaceutical Omadacycline API Product Portfolio
  18. 6.3.5 Sichuan Aobang Gude Pharmaceutical Recent Developments
  19. 6.4 Shanghai Desano Chemical Pharmaceutical
  20. 6.4.1 Shanghai Desano Chemical Pharmaceutical Company Information
  21. 6.4.2 Shanghai Desano Chemical Pharmaceutical Business Overview
  22. 6.4.3 Shanghai Desano Chemical Pharmaceutical Omadacycline API Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Shanghai Desano Chemical Pharmaceutical Omadacycline API Product Portfolio
  24. 6.4.5 Shanghai Desano Chemical Pharmaceutical Recent Developments
  25. 6.5 Asymchem Laboratories
  26. 6.5.1 Asymchem Laboratories Company Information
  27. 6.5.2 Asymchem Laboratories Business Overview
  28. 6.5.3 Asymchem Laboratories Omadacycline API Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Asymchem Laboratories Omadacycline API Product Portfolio
  30. 6.5.5 Asymchem Laboratories Recent Developments
  31. 6.6 Hubei Tianshu Pharmaceutical
  32. 6.6.1 Hubei Tianshu Pharmaceutical Company Information
  33. 6.6.2 Hubei Tianshu Pharmaceutical Business Overview
  34. 6.6.3 Hubei Tianshu Pharmaceutical Omadacycline API Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Hubei Tianshu Pharmaceutical Omadacycline API Product Portfolio
  36. 6.6.5 Hubei Tianshu Pharmaceutical Recent Developments
  37. 6.7 Paratek Pharmaceuticals
  38. 6.7.1 Paratek Pharmaceuticals Company Information
  39. 6.7.2 Paratek Pharmaceuticals Business Overview
  40. 6.7.3 Paratek Pharmaceuticals Omadacycline API Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Paratek Pharmaceuticals Omadacycline API Product Portfolio
  42. 6.7.5 Paratek Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Omadacycline API Sales by Country
  2. 7.1.1 North America Omadacycline API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Omadacycline API Sales by Country (2021-2026)
  4. 7.1.3 North America Omadacycline API Sales Forecast by Country (2027-2032)
  5. 7.2 North America Omadacycline API Market Size by Country
  6. 7.2.1 North America Omadacycline API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Omadacycline API Market Size by Country (2021-2026)
  8. 7.2.3 North America Omadacycline API Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Omadacycline API Sales by Country
  2. 8.1.1 Europe Omadacycline API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Omadacycline API Sales by Country (2021-2026)
  4. 8.1.3 Europe Omadacycline API Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Omadacycline API Market Size by Country
  6. 8.2.1 Europe Omadacycline API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Omadacycline API Market Size by Country (2021-2026)
  8. 8.2.3 Europe Omadacycline API Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Omadacycline API Sales by Country
  2. 9.1.1 Asia-Pacific Omadacycline API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Omadacycline API Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Omadacycline API Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Omadacycline API Market Size by Country
  6. 9.2.1 Asia-Pacific Omadacycline API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Omadacycline API Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Omadacycline API Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Omadacycline API Sales by Country
  2. 10.1.1 South America Omadacycline API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Omadacycline API Sales by Country (2021-2026)
  4. 10.1.3 South America Omadacycline API Sales Forecast by Country (2027-2032)
  5. 10.2 South America Omadacycline API Market Size by Country
  6. 10.2.1 South America Omadacycline API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Omadacycline API Market Size by Country (2021-2026)
  8. 10.2.3 South America Omadacycline API Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Omadacycline API Sales by Country
  2. 11.1.1 Middle East and Africa Omadacycline API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Omadacycline API Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Omadacycline API Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Omadacycline API Market Size by Country
  6. 11.2.1 Middle East and Africa Omadacycline API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Omadacycline API Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Omadacycline API Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Omadacycline API Value Chain Analysis
  2. 12.1.1 Omadacycline API Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Omadacycline API Production Mode & Process
  7. 12.2 Omadacycline API Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Omadacycline API Distributors
  10. 12.2.3 Omadacycline API Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst